Skip to main content

Day: January 30, 2024

Franklin Electric Schedules Its Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call

FORT WAYNE, Ind., Jan. 30, 2024 (GLOBE NEWSWIRE) — Franklin Electric Co., Inc. (NASDAQ: FELE) will release its fourth quarter and fiscal year 2023 earnings at 8:00 am ET on Tuesday, February 13, 2024. A conference call to review earnings and other developments in the business will commence at 9:00 am ET. The fourth quarter and fiscal year 2023 earnings call will be available via a live webcast. The webcast will be available in a listen only mode by going to: https://edge.media-server.com/mmc/p/y88zfrpv For those interested in participating in the question-and-answer portion of the call, please register for the call at the link below. https://register.vevent.com/register/BI7028d9118f904de0860c8fee5c50244a All registrants will receive dial-in information and a PIN allowing them to access the live call. It is recommended that you...

Continue reading

Terra Balcanica Intercepts 551 g/t AgEq Over 4.8 m At Cumavici Ridge in Bosnia and Herzegovina

News Release Video: Terra Balcanica produced a technical webinar to explain the drill results Vancouver, British Columbia, Jan. 30, 2024 (GLOBE NEWSWIRE) — Terra Balcanica Resources Corp. (“Terra” or the “Company”) (CSE:TERA; FRA:UB1) is pleased to announce the final geochemical assay results from the Phase II drill campaign at Cumavici Ridge confirming continuation of the high-grade epithermal vein mineralization at the Viogor-Zanik project in Bosnia and Herzegovina. HighlightsDrillhole CMV23001 intersected 551 g/t AgEq over 4.8 m from 11 m downhole with a further mineralized interval of 669 g/t AgEq over 0.3 m from 31.60 m (Table 1);Drillhole CMV23001 is located on the same platform as previously CMV23002b which returned 499 g/t AgEq over 3.8 m from 22 m reported (see Company news release 17 January 2024);The Cumavici Ridge...

Continue reading

Fiverr’s Winter Product Release: Packed With New Features to Keep Businesses and Freelancers Ahead of The Game and Introducing Fiverr Agencies

Plus, a reimagined homepage, a new consulting category, and an updated review and leveling system to transform the relationship between businesses and freelancers and moreFiverr’s Winter Product ReleaseFiverr’s Winter Product Release includes the introduction of Fiverr Agencies, designed to meet the unique needs of agency teams, a reimagined homepage, a new consulting category, and an updated review and leveling system to transform the relationship between businesses and freelancers and more.Fiverr’s Winter Product Release includes Fiverr Agencies, a reimagined homepage, a new consulting category, and an updated review and leveling system to transform the relationship between businesses and freelancers and more.NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) — Fiverr (NYSE: FVRR), the company...

Continue reading

Energica Inside Signs Agreement with Nimbus to Provide Customized Electric Powertrain

Ideanomics AttachmentModena, Italy, Jan. 30, 2024 (GLOBE NEWSWIRE) — Energica Inside, the business unit of Energica Motor Company (a majority-owned subsidiary of Ideanomics (NASDAQ: IDEX)) dedicated to developing innovative solutions for e-mobility leveraging Energica’s unique technical know-how and IP, has signed an agreement to provide technology to help electrify the historic Nimbus Model C motorcycle.  Nimbus is a motorcycle brand with a rich history, having been produced by Fisker and Nielsen of Copenhagen, Denmark, from 1919 to 1960. Nimbus has successfully achieved near-legendary status in Denmark and around the world due to its iconic design and character. As part of the agreement Energica Inside will support Nimbus’s release of the classic Model C as an electric motorcycle. Carlo Iacovini, General Manager of Energica...

Continue reading

Sensus Healthcare to Host Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call on Thursday, February 8, 2024

BOCA RATON, Fla. , Jan. 30, 2024 (GLOBE NEWSWIRE) — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, February 8, 2024 at 4:30 p.m. Eastern time to discuss the financial results for the fourth quarter and full year 2023. In addition, management will provide a business update and a discussion on recent and upcoming milestones. Participants are encouraged to pre-register for the conference call using this link. Upon registration participants will receive a unique dial in number that will permit them to bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. Those without internet...

Continue reading

INmune Bio Announces FDA Removal of Clinical Hold for Alzheimer’s Disease Program

The Phase II clinical trial in patients with Alzheimer’s disease with neuroinflammation is on track to complete enrollment mid-2024 with top line data expected approximately six months after the final patient is enrolled.   BOCA RATON, Florida, Jan. 30, 2024 (GLOBE NEWSWIRE) — INmune Bio Inc. (NASDAQ: INMB)  (the “Company”), a clinical-stage immunology company targeting microglial activation and neuroinflammation as a cause of Alzheimer’s disease (AD) with XProTM (XPro1595; pegipanermin), a dominant-negative inhibitor of soluble TNF, received correspondence from the FDA confirming that the full clinical hold on the Company’s AD clinical trial program has been lifted. The Phase II trial is on track to enroll the last patient mid-2024. Top line data is expected approximately six months after the last patient is enrolled. “We are...

Continue reading

Motus GI Holdings Publishes Positive Results from a European Study of the Second Generation Pure-Vu System in Improving Visualization for Colonoscopy in Patients with a History of Poor Bowel Preparation

FORT LAUDERDALE, Fla., Jan. 30, 2024 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc. (Nasdaq: MOTS, or “Motus GI” or “the Company”), a medical technology company focused on improving endoscopic outcomes and experiences, announced today the publication of positive data from a study of the second generation Pure-Vu System in a manuscript titled, “An intraprocedural bowel cleansing system for difficult-to-prepare patients—A multicenter prospective feasibility study,” in the peer-reviewed journal, United European Gastroenterology (UGE). The Company’s Pure-Vu System is an FDA-approved and CE-certified bowel cleansing system (BCS) intended to increase visualization in inadequately prepared colons by offering intraprocedural cleansing. “We are excited to see the positive results from this European study published in the UGE Journal, further...

Continue reading

Mizuho Americas Invests in DirectBooks

NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) — Mizuho Americas today announced its strategic investment in DirectBooks®, the leading primary markets communications platform. Through this investment, Mizuho will join the board of directors and work directly with other top-tier investment banks to enhance capital markets globally. “DirectBooks has emerged as an important provider of innovative solutions for the capital markets,” said Jerry Rizzieri, President and CEO, Mizuho Securities USA. “We look forward to playing a larger role in their continued success.” DirectBooks is a fintech bank consortium founded with the goal of optimizing capital markets through streamlined communication resulting from structured deal data, documentation, and information exchange. Mizuho Americas joined the DirectBooks platform as the first non-consortium...

Continue reading

goeasy Ltd. Announces Timing of Fourth Quarter 2023 Conference Call and Webcast

MISSISSAUGA, Ontario, Jan. 30, 2024 (GLOBE NEWSWIRE) —  goeasy Ltd. (TSX: GSY), (“goeasy” or the “Company”), one of Canada’s leading non-prime consumer lenders, will hold a conference call with shareholders, analysts, and portfolio managers on Wednesday, February 14, 2024. A media release including goeasy Q4 2023 results will be issued after the market closes on Tuesday, February 13, 2024. Date: Wednesday, February 14, 2024 Time: 11:00 am ET Dial-in: Use the link https://register.vevent.com/register/BI4bff80379a124f35890a33569bbd294c to pre-register for the conference call and obtain your dial-in number and unique PIN. A recorded version will be available under the same link immediately following the conclusion of the conference call. Webcast: https://edge.media-server.com/mmc/p/agqex44d Media are invited to listen to the...

Continue reading

Terra Balcanica Intercepts 551 g/t AgEq Over 4.8 m At Cumavici Ridge in Bosnia and Herzegovina

Figure 1.Geological map illustrating the drillholes at the Cumavici Ridge locality. AgEq values are labelled for selected 2022 and 2023 drill intercepts (See Company’s new releases dated 13 November 2023, 27 February 2023, 17 January 2024). Current drilling efforts confirm mineralization over 82 m NW/SE strike length. (WGS84/UTM Zone 34N)Figure 2.Drillhole section through step out drill fence located 42 m SE of the 2022 discovery holes at Cumavici Ridge. Assay intervals reported for CMV23001.News Release Video: Terra Balcanica produced a technical webinar to explain the drill results VANCOUVER, British Columbia, Jan. 30, 2024 (GLOBE NEWSWIRE) — Terra Balcanica Resources Corp. (“Terra” or the “Company”) (CSE:TERA; FRA:UB1) is pleased to announce the final geochemical assay results from the Phase II drill campaign...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.